Serum calprotectin as new biomarker for disease severity in idiopathic pulmonary fibrosis: a cross-sectional study in two independent cohorts
Background Non-invasive biomarkers for the assessment of disease severity in idiopathic pulmonary fibrosis (IPF) are urgently needed. Calprotectin belongs to the S-100 proteins produced by neutrophils, which likely contribute to IPF pathogenesis. Calprotectin is a well-established biomarker in infla...
Guardado en:
Autores principales: | Maria Molina-Molina, Carlos Machahua, Sabina A. Guler, Michael P. Horn, Lurdes Planas-Cerezales, Ana Montes-Worboys, Thomas K. Geiser, Manuela Funke-Chambour |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9c29f3d8a4784a128929e9c462286e17 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Relationship between body composition, exercise capacity and health-related quality of life in idiopathic pulmonary fibrosis
por: Martijn A Spruit, et al.
Publicado: (2021) -
Impact of high-flow oxygen therapy during exercise in idiopathic pulmonary fibrosis: a pilot crossover clinical trial
por: Diana Badenes-Bonet, et al.
Publicado: (2021) -
Validation of the risk stratification score in idiopathic pulmonary fibrosis: study protocol of a prospective, multi-centre, observational, 3-year clinical trial
por: Gian Marco Manzetti, et al.
Publicado: (2021) -
Longitudinal serological assessment of type VI collagen turnover is related to progression in a real-world cohort of idiopathic pulmonary fibrosis
por: Henrik Jessen, et al.
Publicado: (2021) -
Lung ultrasound for the diagnosis of cystic fibrosis pulmonary exacerbation
por: Maryam Hassanzad, et al.
Publicado: (2021)